The Gross Margin of Lineage Cell Therapeutics Inc (LCTX) is 96.48%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 96.48% |
| 2023-12-31 | 92.50% |
| 2022-12-31 | 95.10% |
| 2021-12-31 | 67.28% |
| 2020-12-31 | 78.69% |
| 2019-12-31 | 88.07% |
| 2018-12-31 | 93.99% |
| 2017-12-31 | 95.09% |
| 2016-12-31 | 94.09% |
| 2015-12-31 | 84.23% |